Christopher Charles Evans

Mr. Christopher Charles Evans

University of Georgia, Athens, Alabama, USA
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2014 in BMC Genomics
Verified
Journal Article
Open access
PDF file
ALAshley N Luck
Ashley N Luck
CEChristopher Charles Evans
Christopher Charles Evans
MRMolly D Riggs
Molly D Riggs
JFJeremy M Foster
Jeremy M Foster
AMAndrew R Moorhead
Andrew R Moorhead
MMMichelle L Michalski
Michelle L Michalski
Dirofilaria immitis, or canine heartworm, is a filarial nematode parasite that infects dogs and other mammals worldwide. Current disease control relies on regular administration of anthelmintic preventives, however, relatively poor compliance and evidence of developing drug resistance could warrant alternative measures against D. immitis and related human filarial infections be taken. As with many other filarial nematodes, D. immitis contains Wolbachia, an obligate bacterial endosymbiont thought to be involved in providing certain critical metabolites to the nematode. Correlations between nematode and Wolbachia transcriptomes during development have not been examined. Therefore, we detailed the developmental transcriptome of both D. immitis and its Wolbachia (wDi) in order to gain a better understanding of parasite-endosymbiont interactions throughout the nematode life cycle.

1 November 2017 in Veterinary Parasitology
Verified
Journal Article
Closed access
CEChristopher Charles Evans
Christopher Charles Evans
AMAndrew R. Moorhead
Andrew R. Moorhead
BSBobby E. Storey
Bobby E. Storey
BBByron L. Blagburn
Byron L. Blagburn
AWAdrian J. Wolstenholme
Adrian J. Wolstenholme
RKRay Kaplan
Ray Kaplan

28 April 2023 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
CEChristopher Charles Evans
Christopher Charles Evans
DNDorothy Normile
Dorothy Normile
SGSheryl Gamble
Sheryl Gamble
FGFrank Guerino
Frank Guerino
MDMichael T. Dzimianski
Michael T. Dzimianski
AMAndrew Riddell Moorhead
Andrew Riddell Moorhead
Background: Mosquitoes serve as the vector of canine heartworm (Dirofilaria immitis), which represents a significant and persistent threat to canine health. A reduction in the longevity and/or reproductive success of mosquitoes that take a blood meal from fluralaner-treated dogs may consequently reduce the local transmission of heartworm and prevent new infections. A novel secondary effect of an oral formulation of the ectoparasiticide fluralaner (Bravecto®) against a laboratory strain of the mosquito Aedes aegypti, a potential major vector of canine heartworm, was investigated in this study. Methods: Six dogs were administered a single dose of fluralaner orally in the form of Bravecto® Chews (at the labeled fluralaner dose of 25 mg/kg body weight), while six control dogs received no treatment. Mosquitoes were fed on blood that was collected from each dog prior to treatment and weekly for 15 weeks post-treatment to assess the continued effects of fluralaner as its serum level decreased. Mosquito fitness was assessed by three parameters: rate of successful blood-feeding, survival, and egg laying. Results: Successful blood-feeding rate was similar between control and treatment groups. In the fluralaner treatment, mosquito survival was significantly reduced within the first 24 h after blood-feeding, for the first 12 weeks post-treatment of the dogs (efficacy range = 33.2–73.3%). Survival of mosquitoes up until a potentially heartworm-infective timepoint (14 days post-blood-feeding) was significantly reduced in the fluralaner-treated group at several timepoints (1, 2, 5, 11, 12, 13, 14, and 15 weeks post-treatment; efficacy range = 49.4–91.4%), but was less consistently reduced at the other timepoints. Egg laying by mosquitoes was almost completely suppressed for the first 13 weeks following treatment of the dogs with fluralaner (treatment efficacy ≥ 99.8%). Conclusions: Mosquitoes fed blood from fluralaner-treated dogs experienced a significant reduction in survival and fecundity. These findings support the potential for a reduction in heartworm transmission directly by lethal effects on the vector and indirectly through a reduction of the local vector population when mosquitoes are exposed to animals treated with fluralaner. Graphical

1 December 2019 in Veterinary Parasitology
Verified
Journal Article
Closed access
CEChristopher Charles Evans
Christopher Charles Evans
JBJenna L. Bradner
Jenna L. Bradner
MSMolly D. Savadelis
Molly D. Savadelis
CNC. Thomas Nelson
C. Thomas Nelson
AMAndrew R. Moorhead
Andrew R. Moorhead

23 August 2024 in Pathogens
Verified
Journal Article
Open access
PDF file
CEChristopher Charles Evans
Christopher Charles Evans
NPNils Pilotte
Nils Pilotte
AMAndrew R Moorhead
Andrew R Moorhead
Filarial nematodes of the genus Brugia include parasites that are significant to both human and veterinary medicine. Accurate diagnosis is essential for managing infections by these parasites and supporting elimination programs. Traditional diagnostic methods, such as microscopy and serology, remain vital, especially in resource-limited settings. However, advancements in molecular diagnostics, including nucleic acid amplification tests, offer enhanced sensitivity and specificity. These techniques are becoming increasingly field-friendly, expanding their applications in diagnostics. By refining existing methods, developing novel biomarkers, and understanding the zoonotic potential of various Brugia species, it is possible to improve control measures and better support elimination efforts.

9 November 2017 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
AMAndrew R Moorhead
Andrew R Moorhead
CEChristopher Charles Evans
Christopher Charles Evans
RKRay Kaplan
Ray Kaplan
The emergence of macrocyclic lactone resistance in canine heartworm poses a substantial threat to what is currently the only effective, FDA-approved available method of prevention. Further study of the biotypes is necessary to understand the mechanism of resistance and evaluate novel prevention options. Identifying cases of drug-resistant infection remains problematic, however, especially when poor compliance and insufficient testing are concerns. Furthermore, a definitive demonstration of resistance requires experimental infection and treatment, which is prohibitively costly. With the aim of identifying likely cases of macrocyclic lactone-resistant heartworm and preventing their continued spread, we describe an algorithm for determining the likelihood of drug resistance and appropriate treatment strategies for each case. This algorithm relies on the microfilarial suppression test (MFST), which has been used previously as an efficient and discrete measure of suspected resistance. By standardizing this method in a format that is readily available to practitioners, it could become possible to preliminarily survey the emergence and spread of resistance. Heartworm isolates identified through this method can be used in research to better understand macrocyclic lactone resistance so prevention strategies can be adapted.